BellyProof
Members
Join
00:00Limited-time offerSee sale pricesStart your longevity protocolBecome BellyProofJOIN
Cellular telomere visualization at high magnification illustrating biological healthspan and anti-aging biology
SCIENCE · CELLULAR LONGEVITY

Healthspan + Senolytics: The 12 Hallmarks of Aging Guide

Healthspan beats lifespan: the 12 hallmarks of aging, plus senolytics, NAD+, mitophagy, glycation and the inputs that actually move biological age.

Read the science
Science By Jacob Nadav Founder · FRC · ELDOA · FMS L2 60 min read
  1. Healthspan vs lifespan
  2. The 12 hallmarks framework
  1. Healthspan vs lifespan
  2. The 12 hallmarks framework
  3. 1. Genomic instability + Nrf2
  4. 2. Telomere attrition
  5. 3. Epigenetic alterations
  6. 4. Loss of proteostasis
  7. 5. Disabled macroautophagy
  8. 6. Nutrient sensing (mTOR/AMPK/NAD+)
  9. 7. Mitochondrial dysfunction + mitophagy
  10. 8. Cellular senescence + senolytics
  11. 9. Stem cell exhaustion
  12. 10. Intercellular communication
  13. 11. Inflammaging
  14. 12. Dysbiosis
  15. Glycation + AGEs
  16. Biological age vs chronological age
  17. How to slow biological aging
  18. Frontier research
  19. References
  • chronological
  • biological

Which one is yours?

Most anti-aging writing reads the wrong direction. It starts with the supplement, the regimen, the morning routine, then back-fills a mechanism. That sequence breaks down on contact with biology.

The order this page runs in is the inverse. Start with the hallmark, the measurable cellular state. Trace it to the pathway that produced it. Only then ask what input modifies that pathway, and at what dose, and with what evidence behind it. The interventions that survive this filter all turn out to be the same small set.

What you'll learn on this page
  1. The twelve hallmarks of aging as cellular states, not symptoms.
  2. How mTOR, sirtuins, autophagy and mitochondrial quality control connect every hallmark to a single set of inputs.
  3. Why protein cycling and fasting windows outperform almost every popular supplement.
  4. A ranked intervention table: which inputs have strong evidence, which are speculative, and which are noise.

Healthspan vs Lifespan: Why the Difference Matters

Lifespan is how long you live. Healthspan is how long you live well. The gap between the two is the part of life almost nobody talks about, and it is where every decision in this guide actually lands.

Healthspan Lifespan
birth78 years

The math is brutal. The average person now lives roughly 78 years, but spends the last 12 to 15 of those years managing chronic conditions, declining muscle, declining cognition, and declining independence. Lifespan extension without healthspan extension is a longer window of frailty, not a longer window of vitality.

Healthspan is not a soft wellness concept. It maps to measurable cellular states. When the hallmarks of aging, telomere attrition, mitochondrial dysfunction, loss of proteostasis, cellular senescence and the others laid out below, accumulate, healthspan ends. When those hallmarks are slowed or reversed, healthspan extends. The whole point of cellular longevity research is to compress the period of decline at the end of life, not necessarily to extend total years.

This is also why the framing on this page runs in the order it does. We do not start with the supplement, the regimen, or the morning routine and back-fill biology. We start with the cellular state, the hallmark, trace it to the pathway, then ask what input modifies that pathway and what the evidence actually shows. The interventions that survive that filter all turn out to be the same small set: protein cycling, fasting windows, deep sleep, training stress, and a few targeted compounds with real evidence. Most of what gets sold as "anti-aging" never makes it through.

If your goal is to age well, to maintain cognitive sharpness, muscle, metabolic flexibility, and mobility into your seventies and eighties, the lever is healthspan, not lifespan. The hallmarks framework below is how you operate that lever.

Why Healthspan Is the Right Target

Three reasons healthspan is the operationally useful number, not lifespan:

  1. Healthspan is modifiable today. The interventions on this page move cellular states that determine healthspan, autophagy, mitochondrial quality control, senescent cell load, in humans, in published trials. Lifespan extension in humans is still inferential, drawn from biomarker shifts and animal studies.
  2. Healthspan compounds. Each year of healthy function lets you train harder, sleep better, eat better, and recover faster the next year. Each year of decline pulls the next year down with it. This is why interventions started in the forties and fifties produce disproportionately better results than the same interventions started at seventy.
  3. Healthspan is what people actually want. When asked, almost no one says they want to live to 95 if the last fifteen years involve cognitive decline and loss of mobility. They want to live well, and to keep living well, and to compress the end. That is the healthspan goal.

The rest of this guide treats lifespan as a downstream byproduct. The work, and the evidence, is in the hallmarks.

The 12 Hallmarks of Aging: A Mechanism-First Map

The hallmarks of aging are the cellular states that define what aging actually is. They are not symptoms. They are not lifestyle factors. They are measurable, mechanistic processes happening inside your cells right now, and the rate at which they accumulate is the rate at which you age.

  1. It manifests during normal aging, not just in disease states.
  2. Experimentally accelerating it shortens healthspan or lifespan in model organisms.
  3. Reversing or slowing it extends healthspan or lifespan.
1 Genomic Instability 2 Telomere Attrition 3 Epigenetic Alterations 4 Loss of Proteostasis 5 Disabled Macroautophagy 6 Deregulated Nutrient Sensing 7 Mitochondrial Dysfunction 8 Cellular Senescence 9 Stem Cell Exhaustion 10 Altered Intercellular Communication 11 Chronic Inflammation 12 Dysbiosis

The Twelve Hallmarks

  1. Genomic Instability, DNA damage from reactive oxygen species, replication errors, and environmental insults outpaces the cell's repair machinery.
  2. Telomere Attrition, the protective caps on chromosomes shorten with each cell division, eventually triggering replicative senescence.
  3. Epigenetic Alterations, methylation patterns drift over time; this drift is what biological age tests measure via the epigenetic clock.
  4. Loss of Proteostasis, the cell's quality-control system for proteins, including the ubiquitin-proteasome system, degrades.
  5. Disabled Macroautophagy, cellular self-cleaning slows; damaged organelles and protein aggregates accumulate.
  6. Deregulated Nutrient Sensing, mTOR, AMPK, sirtuins and the insulin/IGF-1 axis lose their tight regulation.
  7. Mitochondrial Dysfunction, energy production declines, mitophagy slows, and reactive oxygen species rise.
  8. Cellular Senescence, cells stop dividing but stay metabolically active, secreting inflammatory signals (the SASP) that damage neighbouring tissue.
  9. Stem Cell Exhaustion, the cells that replace damaged tissue lose proliferative capacity.
  10. Altered Intercellular Communication, hormonal, neuronal, and inflammatory signalling between cells degrades.
  11. Chronic Inflammation (Inflammaging), low-grade systemic inflammation that compounds nearly every other hallmark.
  12. Dysbiosis, the gut microbiome shifts toward inflammatory species and loses metabolic diversity.

Listed in the order this guide treats them, with the dominant pathway each connects to. Each links to its dedicated section below.

The hallmarks are not independent. They feed on each other. Reactive oxygen species damage telomeres. Short telomeres trigger senescence. Senescent cells inflame mitochondria. Failing mitochondria generate more reactive oxygen species. Inflammaging accelerates all of the above. This is why a small number of interventions, protein cycling, fasting windows, deep sleep, training stress, touch multiple hallmarks at once and produce disproportionate effects. It is also why no single supplement closes the loop.

What follows is each hallmark in detail, the pathway it connects to, and the inputs that have the strongest evidence for moving it.

The framework was first formalised by López-Otín and colleagues in Cell in 2013, which named nine hallmarks that consistently appeared across age-related decline. The 2023 update, "Hallmarks of Aging: An Expanding Universe", expanded that to twelve, adding disabled macroautophagy, chronic inflammation, and dysbiosis as distinct processes that earlier work had folded into other hallmarks. The twelve-hallmark version is the one this guide uses, because it more accurately separates pathways that respond to different interventions.

Each hallmark satisfies three criteria, per the original paper:

That third criterion is what makes the framework useful for someone trying to operate on their own biology. Every hallmark has been demonstrated, in at least one model organism, to respond to a specific intervention. Some of those interventions translate cleanly to humans. Some are still speculative. The job of this guide is to draw the line between the two.

FREE AI TOOL

See your BellyProof transformation before you start

Free AI body scan reads where you are now and projects you forward through fat loss and muscle building. No signup. 90 seconds.

Preview the System

60+ muscle programs 4 fat loss protocols 15 Club Mitochondria modules

Hallmark 1 of 12

1. Genomic Instability

Genomic instability is the slow accumulation of unrepaired damage to your DNA. Your cells take roughly tens of thousands of DNA hits every day, from reactive oxygen species generated by normal metabolism, from replication errors when cells divide, from UV light, and from environmental toxins. A repair machinery handles most of those hits. With age, the repair machinery loses pace with the damage rate, and the unrepaired errors compound.

Damage rate they cross Repair capacity
youngerolder

This is the hallmark that ties oxidative stress and aging together at a mechanistic level. Reactive oxygen species, the byproducts of mitochondrial energy production, are the dominant endogenous source of genomic damage. Antioxidants do not erase damage that has already happened; they reduce the rate at which new damage occurs. The body has its own antioxidant machinery to handle this, anchored by a master regulator called Nrf2.

Nrf2: The Master Antioxidant Switch

Nrf2 is the transcription factor that turns on roughly 200 genes involved in antioxidant defence, detoxification, and DNA repair. It is the cell's own response to oxidative stress. When Nrf2 activity is high, the cell produces glutathione, superoxide dismutase, catalase, and the rest of the endogenous antioxidant system. When Nrf2 activity falls, as it does with age, oxidative damage outpaces clearance and genomic instability accelerates.

The practical implication is that the most effective antioxidant strategy is not flooding the body with vitamin C megadoses. It is activating Nrf2 so the body produces its own antioxidants on demand. Nrf2 is activated by hormesis, the same low-dose stress signals that trigger most longevity pathways. Sulforaphane (from cruciferous vegetables, especially broccoli sprouts), polyphenols, intermittent fasting, exercise, cold exposure, and heat exposure all activate Nrf2.

This is why the antioxidant paradox exists: high-dose synthetic antioxidants in pill form sometimes blunt the hormetic signal that activates Nrf2 and the rest of the cellular defence system. The body adapts to less oxidative stress by producing fewer endogenous antioxidants. Net result: less protection, not more. The strongest evidence for antioxidant benefit comes from food sources that activate Nrf2, not from isolated supplements.

  • sulforaphane
  • polyphenols
  • intermittent fasting
  • exercise
  • cold exposure
  • heat exposure

DNA Repair and the Pace of Aging

The cell has multiple DNA repair pathways: base excision repair, nucleotide excision repair, mismatch repair, and double-strand break repair. Each declines with age, and each has a documented genetic disease that demonstrates what happens when the pathway fails. Werner syndrome, a defect in a helicase involved in DNA repair, produces a phenotype that looks like accelerated aging in young people. Hutchinson-Gilford progeria, a defect in nuclear envelope structure that compromises DNA stability, produces severe accelerated aging. These rare diseases are what told the field, decades ago, that genomic instability is causal in aging rather than just correlated with it.

The interventions with the strongest evidence for slowing genomic instability all activate Nrf2 or the broader stress-response machinery: regular exercise, time-restricted feeding, deep sleep (during which DNA repair is upregulated), and a diet weighted toward polyphenol-rich plants. Supplemental NAD+ precursors are downstream of this and discussed under Mitochondrial Dysfunction; they support repair enzymes that depend on NAD+ as a substrate. The single most overrated intervention in this category is megadose antioxidant pills.

Hallmark 2 of 12

2. Telomere Attrition

  • chronic oxidative stress
  • chronic psychological stress
  • chronic inflammation
  • smoking
  • poor sleep
  • regular exercise
  • adequate sleep
  • nutrient-dense diet
  • social connection
  • stress regulation

Telomeres are the protective caps at the ends of your chromosomes, and they shorten every time a cell divides. When telomeres reach a critical short length, the cell stops dividing and enters senescence (covered under Hallmark 8). Telomere shortening is one of the cleanest mechanistic links between cell division and aging: every dividing cell ages itself a little with each replication.

The enzyme that maintains telomere length is called telomerase. Most somatic cells in adults have very low telomerase activity, which is why telomeres shorten with age. Stem cells and germline cells maintain telomerase activity. Cancer cells reactivate it, which is what gives them their unlimited replicative capacity, and which is the reason therapeutic telomerase activation is a careful question rather than an obvious win.

How Telomere Shortening Drives Cellular Aging

Telomeres do not shorten at a constant rate. They shorten faster under conditions that accelerate the rest of the hallmarks: chronic oxidative stress, chronic psychological stress, chronic inflammation, smoking, and poor sleep. They shorten slower under conditions that slow the rest of the hallmarks: regular exercise, adequate sleep, nutrient-dense diet, social connection, and stress regulation. Telomere length is therefore a downstream readout of how your other hallmarks are doing, not an independent lever.

Once telomeres reach the Hayflick limit, the cell triggers replicative senescence. The senescent cell stays metabolically active and starts secreting inflammatory signals, the SASP, which is why telomere attrition feeds into both cellular senescence (Hallmark 8) and chronic inflammation (Hallmark 11). Three interconnected hallmarks, one upstream cause.

Can You Lengthen Telomeres? What the Evidence Shows

The honest answer: lifestyle interventions can slow telomere shortening and in some studies modestly extend mean leukocyte telomere length, but no consumer intervention reliably reverses telomere length back to a younger state. The interventions with measurable effects in human studies are: a Mediterranean-pattern diet, regular aerobic exercise, mindfulness-based stress reduction, and adequate sleep duration.

Supplements marketed as "telomerase activators" (most prominently TA-65, derived from astragalus) have small studies showing minor leukocyte telomere extension, but the effect sizes are modest and the long-term safety question, given telomerase reactivation in cancer, remains open. We do not recommend pharmaceutical telomerase activation as a routine intervention until that evidence matures.

The pragmatic position: treat telomere length as a downstream marker of how the rest of the hallmarks are being managed. The interventions that protect telomeres are the same interventions that move every other hallmark. There is no telomere-specific shortcut.

Hallmark 3 of 12

3. Epigenetic Alterations

youngold

Epigenetics is the layer of chemical marks on top of your DNA that decides which genes are switched on and which are switched off. Your genome does not change with age, but the epigenetic marks on it drift, and that drift is what changes which genes actually run. This is why two cells with identical DNA, a young liver cell and an old liver cell, behave so differently.

The dominant epigenetic mark in aging research is DNA methylation: the addition of methyl groups to specific cytosine positions. Methylation patterns at thousands of sites across the genome shift in a predictable, age-correlated direction. Steve Horvath's 2013 paper showed that this drift is so consistent that you can build a mathematical clock from it that estimates a person's age, in years, from their methylation pattern alone.

The Epigenetic Clock and Biological Age

The epigenetic clock is the basis of nearly every commercial biological age test on the market today (TruDiagnostic, Elysium Index, GlycanAge and others use related methylation-based readouts). The clock measures methylation at a panel of CpG sites and returns an estimated biological age, which can be compared against your chronological age to produce a deviation: ahead of your years, on your years, or behind.

The clinically interesting metric is not the absolute biological age number, which has significant variance between testing platforms, but the rate of change in your own readings over time on the same platform. If your epigenetic clock is ticking faster than one year per chronological year, the lifestyle inputs upstream are accelerating the drift. If it is ticking at one or below, they are not. Biological age and how to measure it properly is covered in its own section below.

Methylation Drift vs Cellular Reprogramming

There are two opposing forces on the methylation pattern. Drift is the gradual accumulation of stochastic methylation changes that diverge from the youthful pattern. Reprogramming is an active intervention that resets the pattern back toward youthful state. Drift is what happens to everyone. Reprogramming is what the field is trying to engineer.

The most studied reprogramming intervention is partial expression of the four Yamanaka factors: Oct4, Sox2, Klf4, and c-Myc. Full expression of these factors converts an adult cell back into a pluripotent stem cell, a powerful but unsafe reset (it produces tumours). Partial expression, run in short pulses, appears to roll back methylation age without losing cell identity. This is the active research frontier behind companies like Altos Labs and the broader cellular reprogramming program. We treat the human-translation status of cellular reprogramming under the Frontier Research section below; for everyone reading this in 2026, it is not yet a consumer intervention.

What is available today is upstream: the methylation drift rate responds to the same inputs that move every other hallmark. Exercise, sleep, fasting protocols, and nutrient density all slow the drift. There is no methylation supplement, despite some being sold as such. The best methylation-protective intervention is the boring one: cover the basics hard enough that the clock's slope changes.

Hallmark 4 of 12

4. Loss of Proteostasis

Proteostasis is the cell's quality-control system for proteins. Every cell makes thousands of proteins continuously, folds them correctly, ships them to the right place, and disposes of them when they are damaged or no longer needed. The machinery that runs this, chaperones, the ubiquitin-proteasome system, and the autophagy pathways, keeps the protein population functional. With age, every part of this machinery degrades, and misfolded or damaged proteins accumulate.

Chaperones declines with age
Ubiquitin-proteasome declines with age
Autophagy declines with age

The Three Components of Proteostasis

The cell has three lines of defence for protein quality:

  • Chaperones, including the heat shock proteins, fold newly made proteins into their correct shape and refold proteins that have come apart. Heat shock proteins are upregulated by, predictably, heat stress. This is part of why sauna shows up in healthspan research.
  • The ubiquitin-proteasome system tags damaged proteins with a small molecule called ubiquitin, which marks them for degradation by the proteasome, a barrel-shaped enzyme complex that breaks the protein down into amino acids for reuse.
  • Autophagy, particularly macroautophagy, handles larger aggregates and damaged organelles that the proteasome cannot process. Autophagy gets its own dedicated section as Hallmark 5 below.

All three decline with age. Chaperone capacity drops. Proteasome activity drops. Autophagy drops. The interventions that improve proteostasis are the ones that hormetically stress one or more of these systems: heat exposure (sauna, hot baths) for chaperones, fasting and caloric restriction for proteasome and autophagy, exercise for both. There is no proteostasis pill. There are protein-degradation drugs in clinical development, but consumer access is years out and the upstream lifestyle inputs do most of what is currently available to do.

Loss of proteostasis is the upstream cause of nearly every neurodegenerative disease. Alzheimer's involves amyloid-beta and tau protein aggregation. Parkinson's involves alpha-synuclein. Huntington's involves huntingtin. ALS involves several aggregating proteins including TDP-43. The aggregating protein differs by disease; the upstream failure, the cell's inability to refold or degrade misfolded proteins fast enough, is the same. This is why proteostasis matters operationally even for someone who is not in a clinical disease state: the protein-disposal system is decades-long, and the slope you are on at fifty determines what you have at seventy.

  • Alzheimer's
  • Parkinson's
  • Huntington's
  • ALS
Hallmark 5 of 12

5. Disabled Macroautophagy

1 cargo 2 autophagosome 3 lysosome 4 amino acids
12 to 14 hthe threshold that breaks 16 to 18 hmarkers detectably elevate 24 to 48 hsubstantially higher

Autophagy, literally "self-eating," is the cell's recycling and self-cleaning program. It is how the cell removes damaged organelles, misfolded protein aggregates, and components that are no longer needed, and how it salvages the amino acids and lipids from those components for reuse. Macroautophagy is the dominant form, where a double-membrane vesicle called an autophagosome engulfs the cargo and delivers it to the lysosome for breakdown.

The 2023 hallmarks update separated disabled macroautophagy from the broader proteostasis hallmark for a reason: autophagy responds to a specific set of inputs that are different from the inputs that move chaperones and the proteasome. Yoshinori Ohsumi won the 2016 Nobel Prize in Physiology for autophagy mechanism work, and the field has accumulated strong evidence since then that autophagy decline is one of the hardest-hitting hallmarks in aging.

Why Autophagy Declines With Age

Three things happen. First, the upstream signal that activates autophagy, principally mTOR inhibition and AMPK activation, becomes less responsive with age. Second, the machinery that builds autophagosomes (the ATG protein family) is expressed at lower levels. Third, lysosomal function itself degrades, which means even when autophagosomes form, the cargo inside them is not broken down efficiently. The net result is that the cell accumulates damaged components faster than it can clear them.

This connects directly to nutrient sensing (Hallmark 6) because the dominant signal that turns autophagy on or off is nutrient availability. When nutrients are abundant, mTOR is active and autophagy is suppressed. When nutrients are scarce, mTOR is inhibited, AMPK is activated, and autophagy ramps up. This is why fasting and caloric restriction both extend healthspan in nearly every animal model studied: they turn the autophagy program back on.

Autophagy, Fasting, and Time-Restricted Eating

The intervention with the cleanest mechanism for re-activating autophagy is extended fasting. Roughly 16-18 hours of fasting begins to detectably elevate autophagy markers in human studies, and 24-48 hours produces robust elevation. This is part of the rationale behind time-restricted eating windows of 16:8 or longer, and behind periodic longer fasts in the 24-72 hour range.

Two qualifiers. First, the autophagy benefits of fasting do not require constant fasting. Periodic activation, several days per week of compressed eating windows or a few 24-hour fasts per month, appears sufficient. Constant low-protein, high-fasting living can cost muscle and cognitive function for non-proportional autophagy gains. Second, in sedentary populations the autophagy response to fasting is blunted. Exercise is a separate and additive autophagy activator: it ramps up autophagy in muscle and brain even in the fed state.

The supplements claimed to mimic fasting-induced autophagy (most notably spermidine and some polyphenols) have animal evidence but limited human evidence. Spermidine is the strongest of the candidates and has small human trials suggesting modest benefit; the honest position is that it is not a replacement for the upstream fasting+exercise stack, and supplementing without the lifestyle stack is unlikely to move autophagy meaningfully.

You can keep reading. Or you can see what this looks like in real bodies.

Same mechanism you just read about. Different bodies. Same outcome.

See more results
A man in his seventies holds a plank on a retirement-home carpet while a bingo game continues behind him
Still under construction.
Hallmark 6 of 12

6. Deregulated Nutrient Sensing

The cell continuously senses what nutrients are available and adjusts its growth and repair programs accordingly. Four pathways do most of this work: mTOR (mechanistic target of rapamycin), AMPK (AMP-activated protein kinase), sirtuins, and the insulin/IGF-1 axis. With age, each of these loses its tight regulation, and the cell starts running its growth and repair programs at the wrong intensities at the wrong times. Deregulated nutrient sensing is, in many ways, the most operationally tractable hallmark, because every one of these pathways responds to inputs you control: protein intake, fasting windows, training stress, and a small set of compounds.

mTOR build
  • protein synthesis
  • growth
  • insulin / IGF-1 axis
AMPK repair and recycle
  • fatty acid oxidation
  • mitochondrial biogenesis
  • autophagy
  • sirtuins, NAD+ dependent

mTOR: The Growth Regulator

mTOR is the master switch that tells the cell to build. When it is active, the cell synthesises proteins, builds new tissue, and grows. When it is inhibited, the cell switches into repair and recycling mode, including activating autophagy. Both states are required. The problem in aging is that mTOR stays mildly active at times when it should be off, particularly during fasting windows and during sleep, and the recycling programs never get their full turn.

mTOR is activated by amino acids (especially leucine), by insulin, and by sufficient energy availability. It is inhibited by fasting, by AMPK activation, and by the drug rapamycin, which is the compound the pathway is named after. Rapamycin extends lifespan in every model organism it has been tested in, including mammals, when dosed appropriately. Off-label use of low-dose rapamycin for longevity is an active area of human research; the consumer access question is complicated because rapamycin is a potent immunosuppressant at clinical doses and the longevity dose-response curve in humans is still being mapped. We treat low-dose rapamycin as a Frontier intervention below.

The lifestyle lever for mTOR is protein cycling: periods of high protein intake to support muscle (which most people in their fifties and sixties under-eat), alternated with periods of lower protein and longer fasting windows to allow mTOR to relax. Protein cycling is downstream of this hallmark and is laid out in detail in the "How to Slow Biological Aging" playbook below.

AMPK Activation and Longevity

AMPK is the energy sensor. When cellular energy is low, AMPK activates and turns on the catabolic programs: fatty acid oxidation, mitochondrial biogenesis, and autophagy. It is the antagonist of mTOR. AMPK activation is the unifying signal behind nearly every intervention that extends healthspan: caloric restriction, fasting, exercise, cold exposure, and the drug metformin.

Metformin, originally a type 2 diabetes drug, activates AMPK indirectly via mild inhibition of mitochondrial complex I. The TAME trial (Targeting Aging with Metformin) is the largest human longevity trial in progress and is testing whether metformin extends healthspan in non-diabetic adults. The early biomarker readouts are favourable; the hard endpoint readouts will take years more. Metformin and longevity is the most evidence-based "longevity drug" conversation in 2026; whether the case clears the bar for healthy non-diabetic use depends on the trial outcomes still to come.

Sirtuins: The Longevity Enzymes

Sirtuins are a family of seven enzymes (SIRT1 through SIRT7) that act as deacetylases on DNA, proteins, and metabolic enzymes. They sense the metabolic state of the cell via their dependency on NAD+ as a substrate, and they activate stress-response and DNA-repair programs when the cell is under metabolic stress. Sirtuin activation is a major part of the mechanism by which caloric restriction extends lifespan in animal models.

The sirtuin pathway depends absolutely on NAD+. Without sufficient NAD+, sirtuins do not function. NAD+ levels decline with age, and this decline is one of the strongest biomarkers of cellular aging that we have. This is the pathway that connects sirtuin activation to the NAD+ precursor supplement question.

NMN vs NR: NAD+ Precursor Evidence

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two NAD+ precursors with the most clinical research behind them. Both raise circulating NAD+ in human trials. Both are taken orally. The honest comparison: NR has more peer-reviewed human trials and a longer safety record. NMN has more bench-research support for its hypothetical mechanism, and a vocal consumer following thanks largely to David Sinclair's work, but the human trial base is thinner.

What the NMN/NR human trials have shown so far: yes, both raise NAD+ in blood and tissue. What they have not yet conclusively shown: that the rise in NAD+ translates into extended healthspan endpoints in humans. Animal evidence is robust. Human translation is still in progress. The reasonable position in 2026 is that NAD+ precursors are a biologically plausible intervention with positive surrogate-endpoint data and limited hard-outcome data. They are not snake oil. They are also not yet in the same evidence class as exercise, sleep, and protein cycling.

Caloric Restriction and Longevity

Caloric restriction, sustained eating below energy expenditure without malnutrition, is the longest-studied longevity intervention in biology. It extends lifespan in yeast, worms, flies, mice, rats, and shows healthspan benefits in primates. The CALERIE trial in humans (Calorie Restriction with Adequate Nutrition) showed measurable improvements in inflammation markers, insulin sensitivity, and pace-of-aging biomarkers in non-obese adults restricted by roughly 12% of baseline calories for two years.

The caloric restriction longevity literature is the foundation for the time-restricted eating, fasting-mimicking diet, and intermittent fasting protocols that derive from it. The mechanism, in short: caloric restriction activates AMPK, inhibits mTOR, raises NAD+ indirectly, activates sirtuins, and triggers autophagy. Five separate pathways, one upstream input. This is why caloric restriction (and its time-compressed cousins) has disproportionate effects compared with single-pathway interventions.

The pragmatic alternative, since most people cannot sustain 12% caloric restriction for years, is time-restricted eating: compressing daily intake into a 6-10 hour window. This gets most of the AMPK / mTOR / autophagy benefit without the body composition risk of chronic under-eating, especially when paired with protein cycling and resistance training. The combined protocol is laid out in the playbook section below.

Hallmark 7 of 12

7. Mitochondrial Dysfunction

50% NAD+ levels in tissue, between age 20 and age 60

Mitochondria are the energy plants inside every cell, and their decline is the hallmark that connects most reliably to the felt experience of aging. When mitochondria work, you have energy, recovery, cognitive sharpness, and metabolic flexibility. When they don't, you don't. Mitochondrial dysfunction in aging is not a single failure but a stack: the organelles themselves accumulate damage, the machinery that builds new ones slows, and the machinery that disposes of damaged ones (mitophagy) stops keeping up. Mitochondrial dysfunction in aging therefore compounds with itself: damaged mitochondria leak more reactive oxygen species, which damage more mitochondria, which leak more, and so on.

The intervention question is whether the mitochondrial pool can be improved at the individual cell level. The answer, increasingly, is yes, by activating two specific pathways: mitochondrial biogenesis (building new mitochondria) and mitophagy (clearing damaged ones). Both respond to inputs the average reader can deploy this month.

NAD+ Decline and Mitochondrial Energy

NAD+ (nicotinamide adenine dinucleotide) is the cofactor that mitochondria need to run the electron transport chain. Without NAD+, ATP production stalls. NAD+ levels in tissue decline roughly 50% between age 20 and age 60 in most measured tissues, which is one of the steepest biomarker declines in the entire aging literature. The decline happens for two reasons: production drops, and consumption rises (especially by an enzyme called CD38 that is upregulated by chronic inflammation).

The lifestyle inputs that protect NAD+ are the same ones that move every other hallmark: exercise (especially zone 2 cardio), fasting, and caloric restriction all preserve NAD+ pools. NAD+ precursor supplementation (NMN and NR, covered under Hallmark 6) is a credible adjunct once the lifestyle inputs are in place. It is not a substitute.

CoQ10 and Mitochondrial Respiration

Coenzyme Q10 is the electron carrier that shuttles electrons between complexes I/II and complex III of the electron transport chain. Without CoQ10, the entire electron flow stalls and the proton gradient that drives ATP synthase collapses. CoQ10 levels also decline with age, and statin medications further deplete CoQ10 because the same biosynthesis pathway that produces cholesterol also produces the CoQ10 backbone.

The CoQ10 supplementation evidence is strongest for two specific populations: people on long-term statins (where supplementation reverses the depletion) and people with heart-failure-related fatigue (where supplementation has shown moderate symptom benefit in trials). For healthy adults aiming at longevity, the supplementation evidence is thinner. The body's own CoQ10 production responds to the same hormetic inputs that activate mitochondrial biogenesis, so the upstream lifestyle inputs do most of the work.

Mitophagy: Clearing Damaged Mitochondria

Mitophagy is the targeted form of autophagy that disposes of damaged mitochondria specifically. A healthy cell continuously tags individual mitochondria that have lost membrane potential, encloses them in autophagosomes, and breaks them down for recycling. With age, mitophagy slows for two reasons: the tagging signal (PINK1/Parkin pathway) becomes less sensitive, and lysosomal degradation of the tagged mitochondria stalls.

The result is the accumulation of damaged mitochondria that the cell cannot clear. These damaged organelles are not neutral, they actively leak reactive oxygen species and pro-apoptotic signals. This is one of the dominant drivers of cellular senescence (Hallmark 8) and of muscle decline with age. If you train muscle hard in your fifties and the response is muted compared with your thirties, mitophagy decline is part of why.

Mitophagy responds to specific inputs. Endurance exercise (especially zone 2) is the strongest. Fasting (16+ hour windows) activates it. Cold exposure activates it via the same upstream signal as cold-induced mitochondrial biogenesis. Urolithin A, a metabolite of ellagitannins (found in pomegranates and walnuts), has the strongest supplemental evidence for mitophagy activation, with several human trials showing measurable mitochondrial-function improvement in muscle. Urolithin A is not a magic bullet, but it is one of the few supplements where the human-trial mitophagy evidence is genuinely positive rather than extrapolated from animal models.

PGC-1α and Mitochondrial Biogenesis

PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) is the master regulator of mitochondrial biogenesis. When PGC-1α is activated, the cell builds new mitochondria and upregulates the genes for the electron transport chain, antioxidant defence, and fatty-acid oxidation. PGC-1α is the upstream driver of nearly every mitochondrial benefit you get from exercise.

The activators of PGC-1α are predictable: endurance training (the dominant input), cold exposure, caloric restriction, and the AMPK pathway. This is why a person who trains zone 2 endurance several times per week, even modest amounts, has objectively younger mitochondrial profiles in muscle biopsies than a sedentary person of the same chronological age. PGC-1α activation is the upstream mechanism. Mitochondrial biogenesis is the downstream output.

The pragmatic implication: if mitochondrial dysfunction is a hallmark you want to operate on, the highest-leverage intervention is regular zone 2 cardio plus periodic fasting. Everything else, supplements, peptides, advanced therapies, is an adjunct to that lifestyle stack.

Hallmark 8 of 12

8. Cellular Senescence

Cellular senescence is the state where a cell stops dividing but stays metabolically active. The cell is alive. It maintains its membrane. It generates ATP. It just no longer divides. This sounds harmless, and acutely it is, in fact senescence is a tumour-suppressor mechanism: a cell that has accumulated DNA damage takes itself out of the replication pool to prevent that damage from propagating. The problem is not the senescent cell itself. The problem is what the senescent cell secretes.

Senescent cells release a complex mixture of inflammatory cytokines, chemokines, growth factors, and proteases collectively called the SASP, the senescence-associated secretory phenotype. The SASP turns one senescent cell into a regional inflammation source that damages neighbouring tissue, recruits immune cells, and pushes adjacent healthy cells toward senescence themselves. A small senescent cell load in a young person is cleared by the immune system in days. A larger load in an older person is not, because the immune system has aged in parallel.

How Senescent Cells Accumulate

There are three main triggers that put a cell into senescence:

  1. Replicative senescence, triggered when telomeres reach the Hayflick limit (covered under Hallmark 2). The cell has divided enough times that the telomere cap is too short to protect chromosome ends.
  2. DNA-damage-induced senescence, triggered when a cell accumulates enough DNA damage that the repair machinery cannot keep up. The cell exits the cycle to avoid propagating the damage.
  3. Oncogene-induced senescence, triggered when a mutation in a growth pathway pushes the cell toward uncontrolled division. Senescence is the brake.

All three are protective in the moment. The pathology is the long-term accumulation: by age 60-70, senescent cells are detectable in nearly every tissue at levels that produce measurable SASP-driven inflammation. This is one of the upstream drivers of inflammaging (Hallmark 11) and one of the reasons chronic age-related diseases tend to cluster in the same person, the senescent cell load is global, not organ-specific.

Senolytics: The Intervention Class

Senolytics are compounds that selectively kill senescent cells while sparing healthy cells. The idea was demonstrated in mice in 2015: clearing senescent cells extended healthspan and improved physical function in aged animals. Since then, the field has moved into early human trials, with progress on specific senolytic agents and a parallel line of research on senolytic supplements available today.

The strongest pharmacological senolytic combination in the literature is dasatinib (a cancer drug) plus quercetin (a plant flavonoid). The combination has been tested in small human trials in idiopathic pulmonary fibrosis and in diabetic kidney disease, with measurable reductions in circulating senescent-cell markers. Dasatinib is prescription-only and not a consumer intervention; the research is establishing whether senolytic dosing is even clinically meaningful, not yet whether it should be over-the-counter.

Senolytic Supplements: What the Evidence Actually Says

Two consumer supplements have credible mechanistic claims as senolytics: fisetin and quercetin. Both are plant flavonoids. Both kill senescent cells in cell culture and in mice. The human trial base, however, is still thin.

Fisetin has the strongest preclinical case. In aged mice, a brief high-dose course of fisetin reduced senescent-cell burden across multiple tissues and extended median healthspan. Human trials are in progress but readouts of hard endpoints are years away. The reasonable position in 2026: fisetin has plausible mechanism and animal evidence, modest human safety data at typical supplement doses, and no proof yet of healthspan benefit in people. It is not snake oil. It is also not a confirmed intervention.

Quercetin alone is a weaker senolytic than fisetin in the same models, but it pairs synergistically with dasatinib in the prescription protocols and is a credible plant flavonoid for the broader anti-inflammatory layer. Marketed senolytic stacks (Qualia Senolytic and similar) combine fisetin, quercetin, curcumin, and a few other flavonoids; the human evidence for these specific stacks is essentially zero, despite the marketing. Buy fisetin if you want to try a senolytic supplement; the additive ingredients in the branded stacks do not have evidence for senolytic synergy.

The Honest Position on Senolytics

Senolytics is the area of longevity research where the gap between "cool mechanism in animals" and "intervention you should take this month" is widest. The mechanism is real. Senescent cells genuinely accumulate. Clearing them genuinely helps in animals. The translation to humans is in progress, with the first generation of pharmaceutical senolytics in early-stage trials and the supplement layer (fisetin in particular) having plausible but incomplete evidence.

The pragmatic 2026 position: do not build your healthspan strategy around senolytics. Build it around the lifestyle inputs that prevent senescent-cell accumulation in the first place, exercise, sleep, fasting protocols, nutrient density, and inflammation control. Add fisetin as an experimental adjunct if you want to participate in the n=1 reading on the class. Do not add expensive branded senolytic stacks; they are usually fisetin priced 5x with extra ingredients of no documented benefit.

A grandmother in a knitted hat stands chest-deep in a frozen garden pond, a cup of tea steaming on the bank beside her slippers
Cold is a signal.
Hallmark 9 of 12

9. Stem Cell Exhaustion

Muscle satellite cells
Blood hematopoietic stem cells
Gut intestinal stem cells

Adult stem cells are the cells in each tissue that replace damaged cells with new ones. Muscle has satellite cells. Blood has hematopoietic stem cells. The gut has intestinal stem cells. Each population has the job of maintaining the tissue's regenerative capacity. With age, every stem cell population declines, both in absolute numbers and in the proliferative capacity of the cells that remain. This is stem cell exhaustion, and it is why elderly skin heals more slowly, elderly muscle responds less to training, and elderly immune systems respond less to vaccines.

Stem cell exhaustion is partly a consequence of the upstream hallmarks: telomere attrition limits the number of times a stem cell can divide, DNA damage pushes some into senescence rather than productive division, and the inflammatory environment of aged tissue is hostile to stem cell maintenance. This means the lifestyle interventions that protect upstream hallmarks also protect stem cell function indirectly.

The direct interventions for stem cell aging that have any credible human evidence are limited. Exercise maintains satellite cell function in muscle. Caloric restriction maintains hematopoietic stem cell function. Periodic fasting may activate stem cell renewal in the gut, with some animal evidence and limited human translation. Therapeutic stem cell infusion is a Frontier intervention discussed in the Frontier Research section below; the consumer versions sold at clinics range from genuinely experimental to outright fraudulent, and we do not endorse the consumer market in 2026.

The pragmatic implication: stem cell exhaustion is downstream of the other hallmarks. Move those hallmarks and stem cell function follows. There is no stem cell pill.

Hallmark 10 of 12

10. Altered Intercellular Communication

young tissue
aged tissue
hormonal signal inflammatory cytokine exosome

Cells in a tissue continuously exchange signals: hormones, cytokines, exosomes, and direct contact via gap junctions. The signalling environment of a young tissue is quite different from that of an old tissue. Hormones decline (testosterone, oestrogen, growth hormone, DHEA, melatonin all fall in characteristic patterns). Inflammatory cytokines rise. The composition of circulating exosomes shifts. The result is that even healthy cells in older tissue receive signals that push them toward senescence, dysfunction, or apoptosis faster than the same cells in younger tissue.

The dramatic experimental demonstration of this is parabiosis: surgically connecting the circulatory systems of a young and an old mouse measurably rejuvenates several tissues in the old mouse and ages several tissues in the young mouse. The observation does not work because young blood contains a magic ingredient. It works because intercellular communication is genuinely altered in aged tissue, and replacing the signalling environment partially reverses the dysfunction.

The age-related decline in sex hormones, growth hormone, and DHEA is sometimes framed as a target for direct hormonal replacement. The honest position: hormone replacement is a real intervention with real upside in specific clinical contexts (post-menopausal hormone therapy, clinical hypogonadism in men), but the case for routine longevity-driven hormone replacement in the absence of clinical deficiency is weak. Hormones interact with every hallmark, and pushing them up artificially can accelerate other hallmarks (testosterone replacement can shorten telomeres in some studies; growth hormone replacement in healthy adults can accelerate insulin resistance and possibly some cancer risks). The risk-benefit profile differs sharply between treating a clinical deficiency and pursuing longevity in a healthy person.

The lifestyle inputs that maintain endogenous hormone production, resistance training, adequate sleep, sufficient calories and protein, and stress regulation, do most of the practical work for healthy adults. Direct hormonal replacement is a physician-supervised question for clinically deficient cases.

Exosomes and Circulating Signals

Exosomes are small extracellular vesicles that cells release to communicate at distance. The exosome population in circulation shifts with age: young-tissue exosomes carry signals that promote regeneration, old-tissue exosomes carry signals that promote senescence. This is the basis for exosome therapies and young-plasma exchange protocols, both covered in the Frontier Research section. Consumer access is limited and the evidence base is early, but exosome biology is a credible mechanistic target that links Hallmark 10 to nearly every other hallmark.

Hallmark 11 of 12

11. Chronic Inflammation (Inflammaging)

acute: it resolves chronic: it never returns to zero

Inflammaging is chronic, low-grade, systemic inflammation that develops with age and accelerates nearly every other hallmark. Acute inflammation is essential, it is how the body responds to injury and infection. Chronic inflammation is the same machinery, dialled down to a low simmer that never resolves. The difference matters: acute inflammation is healing, chronic inflammation is damage.

The term inflammaging was coined by Italian immunologist Claudio Franceschi in the 2000s to describe the consistent observation that elderly populations carry elevated inflammatory cytokines (IL-6, TNF-alpha, C-reactive protein) even in the absence of identifiable disease. The elevation is not large in absolute terms, but it is persistent, and persistence is what damages tissue. Inflammaging is now recognised as a causal driver of cardiovascular disease, type 2 diabetes, Alzheimer's, sarcopenia, and frailty, the diseases that statistically determine how the last decades of life feel.

Why Inflammaging Develops

Four main sources, all of which compound:

  • SASP from senescent cells (Hallmark 8). Senescent cells secrete the pro-inflammatory mixture continuously. As senescent cell load rises with age, baseline inflammation rises with it.
  • Mitochondrial dysfunction (Hallmark 7). Damaged mitochondria release DAMPs (damage-associated molecular patterns) that the immune system reads as injury signals.
  • Gut dysbiosis (Hallmark 12). An aged gut microbiome shifts toward pro-inflammatory species and the gut wall becomes more permeable, allowing inflammatory bacterial products into circulation.
  • Immune cell senescence. Aged immune cells lose precision: they over-respond to background signals and under-respond to actual threats. The combined profile is exactly the chronic-low-grade-inflammation pattern.

This is why inflammaging is the hallmark that compounds the others most aggressively. It is downstream of senescence and dysbiosis, and it accelerates genomic instability, telomere attrition, mitochondrial dysfunction, and stem cell exhaustion. A person whose chronic inflammation is poorly controlled is on a faster trajectory through every other hallmark than a person whose chronic inflammation is controlled.

How to Combat Inflammaging

The interventions split into three categories by evidence strength.

Strong evidence, lifestyle layer: regular exercise (especially zone 2 endurance, which dampens systemic inflammation persistently), adequate sleep (deep sleep is when inflammatory cytokines are cleared), Mediterranean-pattern eating (high in olive oil, oily fish, polyphenol-rich plants, low in ultra-processed foods), and visceral fat reduction (visceral fat is itself an endocrine organ that secretes inflammatory cytokines). Each of these has independent human-trial evidence for measurable inflammation reduction over months to years.

Moderate evidence, dietary supplements: omega-3 fatty acids (EPA and DHA) at therapeutic doses (1-4g/day combined EPA/DHA) reliably lower CRP and inflammatory markers in human trials. Curcumin at bioavailable doses has measurable anti-inflammatory effect, modest in size but consistent across studies. Both are credible adjuncts to the lifestyle layer.

Speculative, not yet recommended: low-dose colchicine (used in cardiovascular trials with positive results), low-dose rapamycin (mechanistically appealing, human longevity dose-response unclear), and senolytics (covered above). These are areas where the research is moving fast and physician-supervised use in specific cases may make sense, but they are not consumer interventions in 2026.

The single highest-leverage move on inflammaging is the boring one: chronic exercise, adequate sleep, fewer ultra-processed foods, more polyphenol-rich plants, and visceral fat control. These move inflammation more than any pill, and they do it reliably.

Hallmark 12 of 12

12. Dysbiosis

  • fibre diversity
  • polyphenol-rich plants
  • fermented foods
  • fewer ultra-processed foods

Dysbiosis is the age-related shift in the gut microbiome toward pro-inflammatory species and away from the diverse, fibre-fermenting community that characterises healthy guts. The 2023 hallmarks update added dysbiosis as a distinct hallmark, separate from inflammaging, because the gut microbiome contributes to aging via multiple independent mechanisms: it produces metabolites the host depends on (short-chain fatty acids), it shapes immune system maturation and tone, it modulates barrier integrity, and it interacts directly with the central nervous system via the vagus nerve.

The healthy adult gut hosts a diverse microbial community dominated by fibre-fermenting bacteria (Bacteroidetes and Firmicutes phyla). Aged guts lose diversity, shift toward pro-inflammatory species, and produce less butyrate (the dominant short-chain fatty acid that maintains colonocyte health and barrier integrity). The resulting picture, called "leaky gut" in popular framing and "increased intestinal permeability" in research framing, is the same biological state and is now well-documented in elderly populations.

How Dysbiosis Drives Aging

The mechanism is partly direct and partly via inflammaging. When intestinal permeability increases, bacterial products (lipopolysaccharide, LPS, especially) enter circulation and trigger systemic immune activation. This is one of the primary upstream drivers of inflammaging (Hallmark 11). Reducing dysbiosis therefore reduces inflammation indirectly across the whole body, not just locally in the gut.

The dietary inputs that shape the microbiome are well-characterised: fibre diversity is the strongest single predictor of microbiome diversity, polyphenol-rich plants feed beneficial species, fermented foods (yoghurt, kefir, kimchi, sauerkraut) introduce live beneficial species, and ultra-processed foods consistently favour pro-inflammatory species. The Mediterranean dietary pattern, the dietary pattern that dominates the longevity literature, is essentially a microbiome-supportive eating pattern.

Probiotics and Microbiome Interventions

Probiotic supplementation has a more nuanced evidence base than the marketing implies. Specific strains have specific human-trial evidence: Akkermansia muciniphila for metabolic health, Lactobacillus rhamnosus GG for diarrhoea prevention, Bifidobacterium longum for some inflammation markers. Generic broad-spectrum probiotic capsules without strain specification have weaker evidence and may not survive gastric transit at meaningful doses. Strain-specified probiotics with documented target-condition evidence are credible. Generic capsules less so.

Faecal microbiota transplant from young donors to old recipients is a Frontier intervention with positive animal data and limited human longevity data; consumer access is near-zero outside the clinical recurrent-C. difficile use case. The dominant move on dysbiosis remains dietary: high fibre diversity, polyphenol-rich plants, fermented foods, limited ultra-processed foods. Same answer, different hallmark.

Glycation and Advanced Glycation End Products (AGEs)

Glycation is what happens when sugars in your bloodstream chemically bind to proteins, lipids, and DNA without the cell's permission. Unlike enzymatic glycosylation (a controlled cellular process), glycation is a non-enzymatic, irreversible reaction. Once a protein is glycated, that protein no longer functions correctly. Glycation does not appear in the original 2013 hallmarks list because it cuts across several of them, but it is one of the most consistent biochemical signatures of aging tissue and worth covering as its own pathway.

The end products of this process are called advanced glycation end products, abbreviated AGEs. AGEs accumulate in long-lived proteins, the proteins that do not get recycled often, where they distort structure and cross-link with other proteins. The most visible site of AGE accumulation is the skin, where collagen and elastin are glycated and cross-linked over decades, producing the loss of elasticity and the sagging that marks visible aging. The skintherapyletter literature calls this "sugar sag" for a reason: the mechanism is glycation, and the dietary input is sugar.

Collagen and elastin flexibility and strength Lens of the eye cataract formation Vascular wall arterial stiffening Mitochondria feeds Hallmark 7 RAGE receptor feeds inflammaging

How Glycation Drives Cellular Aging

Glycation is a slow chemical reaction. It happens whenever sugar (especially fructose and glucose) is in contact with proteins, and it accelerates with hyperglycaemia. The faster sugar levels run high, and the longer they stay high, the more glycation occurs. This is why people with poorly-controlled type 2 diabetes age visibly faster, why HbA1c (a measure of glycated haemoglobin) is a clinical proxy for short-term glycation rate, and why skin glycation correlates with serum glucose in non-diabetic populations as well.

The damage from glycation hits multiple targets:

  • Collagen and elastin in skin and connective tissue, which lose flexibility and strength when cross-linked.
  • Proteins in the lens of the eye, where AGE accumulation contributes to cataract formation.
  • Vascular wall proteins, where AGEs stiffen arteries and contribute to cardiovascular aging.
  • Mitochondrial proteins and DNA, where AGEs cross-feed into Hallmark 7 (mitochondrial dysfunction).
  • Receptor binding, where AGEs accumulating on the RAGE receptor (receptor for advanced glycation end products) trigger pro-inflammatory signalling that feeds inflammaging (Hallmark 11).

Diet and Glycation: What Actually Reduces AGE Load

The interventions split cleanly between dietary AGE intake (exogenous AGEs from food) and metabolic AGE production (endogenous AGEs from your own glucose levels).

Exogenous AGEs form when food is cooked at high dry heat, grilling, roasting, frying, broiling. The browning reactions that produce flavour (Maillard reactions) also produce AGEs. The same protein cooked at low wet heat (boiled, steamed, slow-cooked) contains a fraction of the AGE load. Reducing dietary AGE exposure by switching cooking methods has measurable effects on circulating AGE markers in human trials, especially when the change is sustained over months.

Endogenous AGEs are produced by your own metabolism whenever blood glucose runs high. The dominant lever here is everything that improves glycaemic control: fibre with carbohydrates, protein with carbohydrates, walking after meals, time-restricted eating, weight loss in insulin-resistant individuals, and resistance training (which improves muscle glucose uptake). The single highest-leverage move on glycation for most adults is not changing what you eat, it is changing what you eat with what you eat, and how your muscle is conditioned to handle the resulting glucose.

Targeted supplements with anti-glycation evidence are limited. Carnosine and benfotiamine have small human trials suggesting modest reduction in AGE accumulation; both are credible adjuncts to the upstream glycaemic-control work. Topical skincare claims around glycation reduction are mostly speculative; the dominant action on glycation is internal, not topical. Glycation skin damage that has already happened is largely permanent at the AGE level itself, the cross-links do not chemically reverse, but the rate of new accumulation is modifiable.

Biological Age vs Chronological Age

Chronological age is how many years you have been alive. Biological age is an estimate of how old your cells are by measurable markers of cellular state. The two are not always the same. A 45-year-old who has trained hard, slept well, and managed metabolic health for two decades may have a biological age that reads in the mid-thirties. A 45-year-old with chronic visceral adiposity, poor sleep, and persistent inflammation may read in the mid-fifties. The gap between chronological and biological age is the part that is modifiable.

one year per year faster than one year per year the slope you can move chronological age

The reason this distinction matters operationally is that biological age responds to the same lifestyle inputs that move every hallmark on this page, and you can measure the response. Chronological age is fixed. Biological age is the lever.

How Biological Age Is Measured

Several different categories of biological age test exist, with different mechanisms and different precision profiles:

  • Epigenetic clocks (TruDiagnostic, GlycanAge, Elysium Index, MyDNAge). These measure DNA methylation patterns at hundreds to thousands of CpG sites and calculate a biological age estimate. Epigenetic clocks are the most rigorously validated biological age tests in academic literature; the Horvath clock and the GrimAge clock are the canonical examples.
  • Telomere length tests (TeloYears, SpectraCell). These measure the average length of telomeres in white blood cells. Telomere length correlates loosely with biological age but has high individual variance and is influenced by acute factors (illness, stress) that make single-time-point readings noisy.
  • Composite biomarker panels (PhenoAge, function tests). These combine routine blood markers (CRP, albumin, creatinine, glucose, white cell count, etc.) into a composite biological age score. Cheaper than methylation testing and reasonably validated. The Levine PhenoAge calculator is freely available and uses standard blood-panel inputs.
  • AI-derived multimodal estimates (face-aging, retinal scans). The newest category. Some of these have promising research validation; the consumer-grade versions are an emerging market with variable rigour.

Are Commercial Biological Age Tests Worthwhile?

The honest position: the absolute biological age number from any single test has significant noise. Different platforms can return different ages on the same blood sample. The clinically interesting metric is not the absolute number from one reading. It is the rate of change across multiple readings on the same platform over time.

If your epigenetic clock reading rises by less than one year per chronological year, the inputs you are running are slowing the drift. If it rises faster than one year per chronological year, they are not. The slope is what matters, and the slope only becomes visible with at least 2-3 readings spaced 6-12 months apart on the same testing platform. This is the Bryan Johnson biological age framing in compressed form: a single reading is cheap entertainment, a tracked slope is operationally useful information.

For most readers, a credible practical approach is: take the free Levine PhenoAge calculator (uses your routine annual blood panel inputs), get an epigenetic clock reading once per year on the same platform, and watch the slope. The cost-precision sweet spot is not the most expensive test, it is the same test taken consistently over time.

Can You Actually Lower Your Biological Age?

Yes, in tracked individual cases and in small intervention trials, biological age has been shown to reverse modestly with sustained lifestyle change. The CALERIE caloric restriction trial showed measurable slowing of pace-of-aging biomarkers over two years. Small protocols combining exercise, sleep optimisation, dietary change, and stress reduction have produced 2-4 year reductions in epigenetic age in some studies.

The boundaries: do not expect to roll back two decades. The realistic effect size for sustained, comprehensive lifestyle change is in the range of 2-6 years of biological-age reversal over 1-3 years of consistent practice. That is meaningful, it represents measurable cellular state change, but it is not the magic-pill marketing some of the biological-age industry implies. Consistent inputs over time produce measurable reductions. Acute interventions and supplements alone do not.

Can Medications Slow Biological Aging?

Two pharmacological candidates have human evidence for slowing biological-age progression: metformin (covered under Hallmark 6) and low-dose rapamycin (covered under Frontier Research below). The TAME trial is testing metformin specifically on biological-age and aging-related-disease endpoints; the rapamycin longevity literature in humans is earlier-stage but suggests measurable epigenetic-age effects in small cohorts. Both remain physician-supervised interventions with risk-benefit profiles to consider; neither is a consumer over-the-counter intervention in 2026. Lifestyle interventions remain the foundation.

Three generations in towels sit side by side on a sauna bench, staring straight ahead
The boring stack.

How to Slow Biological Aging: Inputs Ranked by Mechanism

The interventions that survive scientific scrutiny for slowing biological aging are a small set, and they all work by hitting multiple hallmarks at once. The generic advice on how to slow aging, eat well, exercise, sleep, manage stress, is correct but mechanism-blind. This section anchors each input to the specific hallmark it operates on, so you can see why these particular practices outperform almost everything sold as "anti-aging", and so you can make an informed call when an alternative is offered.

The inputs are ordered roughly by leverage: how many hallmarks each one moves, weighted by the strength of human evidence. This is also, broadly, the order of how to reverse aging inputs by what the literature actually supports versus what the marketing claims. Aging well, in this framing, is not soft wellness, it is the disciplined application of these specific inputs over years.

  1. 1. Protein Cycling and the mTOR Cycle

    Pathway: Hallmark 6 (deregulated nutrient sensing). Mechanism: the cell needs both growth phases (mTOR active) and repair phases (mTOR inhibited). Constant high protein intake locks mTOR on. Constant low protein loses muscle. Cycling between them gives the cell both states.

    Protein cycling means: most days, eat enough protein to hit 1.6-2.2g/kg lean mass to support muscle in your forties, fifties, and beyond, where age-related sarcopenia is the single biggest threat to healthspan. Then have one or two days per week with longer fasting windows or modestly lower protein, to let mTOR fall, autophagy run, and proteostasis recover. The ratio matters less than the cycling itself.

    This is also why the "protein for longevity is bad" debate is poorly framed, the answer depends entirely on whether you are talking about chronic high protein at the expense of fasting windows (bad for autophagy, fine for muscle), or cycled high protein with periodic fasting (good for both). The cycle is what works.

  2. 2. Time-Restricted Eating and Autophagy

    Pathway: Hallmarks 5 + 6 (autophagy + nutrient sensing). Mechanism: compressing daily food intake into a 6-10 hour window extends nightly fasting beyond the 12-14 hours that breaks autophagy threshold.

    Most people on a typical eating schedule have an effective overnight fasting window of 10-11 hours. Compressing intake to 8 hours produces a 16-hour fast nightly. This is enough to start activating autophagy, drop insulin, and let mTOR cycle off without the body composition cost of constant caloric restriction. The 16:8 protocol is not magic; it is just enough fasting time to consistently get the cellular signals.

    Time-restricted eating combined with protein cycling on a few weekly fasting-emphasised days, plus an occasional 24-48 hour fast every month or two, captures most of the available caloric-restriction benefit without the muscle and bone density cost of chronic under-eating. Several human trials in non-obese adults have shown measurable improvements in inflammatory markers, glucose control, and pace-of-aging biomarkers with this kind of protocol over 12-24 months.

  3. 3. Zone 2 Cardio and Mitochondrial Biogenesis

    Pathway: Hallmark 7 (mitochondrial dysfunction). Mechanism: low-intensity sustained cardio (zone 2, the intensity at which you can hold a conversation) drives mitochondrial biogenesis via PGC-1α activation and mitophagy via metabolic stress.

    The dose that matters in human studies is 150-180 minutes per week of zone 2 effort, distributed across 3-5 sessions. This is the input that most reliably moves mitochondrial function across age groups. People in their fifties who train zone 2 consistently for two years measurably reverse mitochondrial-function markers in muscle. People who do high intensity exclusively get less of this effect, the energy systems are different.

  4. 4. Strength Training and Muscle Stem Cells

    Pathway: Hallmarks 9 + 10 (stem cell exhaustion + intercellular communication). Mechanism: mechanical loading is the strongest signal for muscle satellite cell activation, and resistance-trained muscle is metabolically and endocrinologically younger than untrained muscle.

    The dose that matters: 2-4 sessions per week of progressive resistance training, with sufficient load to drive adaptation. Bodyweight movements are a starting point; loaded strength work is the adaptation driver. The single most consistent intervention for healthspan in adults over 50 is a regular strength training practice. Sarcopenia, the age-related loss of muscle, is the single biggest mechanical limit on independence in the seventies and eighties, and it is preventable.

  5. 5. Deep Sleep and Glymphatic Clearance

    Pathway: Hallmarks 1, 4, 11 (genomic instability + proteostasis + inflammation). Mechanism: deep sleep is when DNA repair is upregulated, when the glymphatic system clears protein aggregates from the brain, and when inflammatory cytokines are cleared from circulation.

    The dose that matters: 7-9 hours total sleep, with adequate deep sleep (typically the first 3-4 hours of the night). Sleep architecture matters more than total time, fragmented 8-hour sleep is worse than consolidated 7-hour sleep. Sleep is the input that compounds with everything else: poor sleep accelerates inflammaging, blunts insulin sensitivity, raises cortisol, and impairs the very recovery processes the rest of this stack depends on.

  6. 6. Cold Exposure and Mitochondrial Biogenesis

    Pathway: Hallmark 7 + Nrf2 activation. Mechanism: cold stress activates brown adipose tissue, drives mitochondrial biogenesis, and triggers a hormetic stress response that activates Nrf2 and the broader antioxidant defence system.

    The dose that matters in human studies: brief cold exposures (cold showers ending in cold water for 1-3 minutes, or cold immersion at 10-15°C for 2-5 minutes), 2-5 sessions per week. The benefit is mechanistic-cellular rather than dramatic, expect modestly improved inflammation markers and metabolic flexibility, not transformation. Cold exposure pairs well with morning practice habits because it also triggers a noradrenaline pulse that supports alertness and mood.

  7. 7. Sauna and Heat Shock Proteins

    Pathway: Hallmark 4 (proteostasis) via heat shock protein activation. Mechanism: heat exposure upregulates the heat shock protein family, which serve as chaperones in protein quality control, and produces cardiovascular conditioning effects via heat-induced changes in plasma volume.

    The dose that matters: 4-7 sessions per week of 15-20 minutes at 80-100°C (Finnish-style dry sauna) shows the strongest associations with reduced cardiovascular mortality and all-cause mortality in observational studies (the Finnish KIHD cohort is the largest). Sauna longevity research is observational rather than randomised, but the dose-response pattern across decades of follow-up is unusual for being remarkably consistent.

8. What Doesn't Work (Or Doesn't Yet)

The interventions sold as anti-aging that do not survive evidence scrutiny are a longer list. The biggest categories: most antioxidant megadose supplements (covered under Hallmark 1, often counterproductive), most generic multivitamin stacks (no longevity evidence in non-deficient adults), branded senolytic stacks (priced fisetin with extra ingredients of no proven synergy), most peptide therapy claims for healthy adults (clinical evidence base is for specific deficiency states, not longevity), and nearly every "reverse aging in 30 days" consumer protocol.

The honest position on aging gracefully and aging well: it is not the supplement stack. It is not the protocol of the month. It is the boring stack run consistently for years. Protein cycling, time-restricted eating, zone 2 cardio, strength training, deep sleep, cold and heat exposure. Each one is mundane in isolation. Together they hit ten of the twelve hallmarks and produce results that compound.

How this connects to the rest of the BellyProof longevity stack. Two of the twelve hallmarks have dedicated mechanism pages of their own. For the dysbiosis hallmark (number 12 above), the practical reset protocol lives in gut reset protocol, where we cover the timing and substrate side of microbiome rebalancing. For the adaptogenic-stress-resilience angle that supports several other hallmarks, our medicinal mushrooms page covers the evidence-based fungal compounds (lion's mane, cordyceps, reishi, chaga) and where they fit relative to the boring-but-foundational stack above.

Where to go from here. If you want to see what the boring stack produces in real members over a long window, the client transformation results page documents outcomes that compound healthspan-relevant biology alongside body composition. The structured version of this stack lives inside the BellyProof program, and if you are ready to apply it with structured guidance you can join BellyProof from there.

Anti-Aging Frontier Research

This section covers the interventions that are scientifically credible but not yet ready for routine consumer use. The mechanisms are real. The animal data is strong. The human translation is in progress, with various interventions sitting at different points along the "works in mice / works in early human trials / approved for clinical use" pipeline. None of these are consumer-grade in 2026, but several will plausibly become so in the next 5-10 years, and understanding the landscape is part of operating an informed longevity practice.

works in mice early human trials approved
Cellular reprogramming preclinical to first trials Exosomes and plasma early and patchy Klotho gene therapy preclinical Low-dose rapamycin physician-supervised off-label Faecal microbiota transplant approved for C. difficile only

Cellular Reprogramming and Yamanaka Factors

Cellular reprogramming is the most ambitious target in the field. The four Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) can convert an adult cell back into a pluripotent stem cell, in effect, resetting the cell to a younger state. Full reprogramming is a tumour risk because pluripotent cells can form teratomas, but partial reprogramming, run in short pulses, appears to roll back the methylation clock and several hallmarks of aging without losing cell identity. The 2020 Lu et al paper demonstrated partial reprogramming reversing age-related vision loss in mice; subsequent work has extended the approach to other tissues.

Altos Labs, founded in 2022 with billions in funding, is the dominant private effort in this space, alongside academic programs at Harvard, Stanford, and the Salk Institute. Translation to human use is still years away, with the first plausible therapeutic applications likely to be tissue-specific rejuvenation rather than whole-body epigenetic reprogramming. Expect the first clinical trials in narrow indications (eye, skin, immune system) rather than systemic anti-aging treatment.

Exosome and Young Plasma Therapies

Exosomes are small vesicles cells use to communicate at distance. Young-tissue exosomes carry signals that promote regeneration; old-tissue exosomes carry signals that promote senescence. Therapeutic exosome infusion (typically derived from young donor cells, often mesenchymal stem cells) is being studied for orthopaedic injury, neurodegenerative disease, and skin rejuvenation. The clinical evidence base is early; consumer clinic offerings exist in the wellness market but the regulation is patchy and the products are heterogeneous.

Young plasma exchange, infusion of plasma from young donors, has limited human longevity data. The Ambrosia trial (which charged for young plasma infusions) was shut down by the FDA in 2019 for unsupported claims. Subsequent academic work on more targeted plasma fractionation (specific protein components rather than whole plasma) is ongoing. The honest position: parabiosis-style interventions are biologically plausible, but the consumer products available today rest on inadequate evidence.

Klotho Gene Therapy

Klotho is a longevity-associated protein. Mice with elevated klotho expression live 20-30% longer; mice with klotho deficiency age rapidly. Klotho supplementation in animal models improves cognitive and renal function. Gene therapy approaches to elevate klotho expression in humans are in preclinical development; the first plausible human trials are likely in neurodegenerative disease rather than as a general longevity intervention. Consumer access is essentially zero in 2026 and likely to remain so for years.

Low-Dose Rapamycin for Longevity

Rapamycin (sirolimus) extends lifespan in every model organism it has been tested in, including mice, when dosed appropriately. In humans, low-dose intermittent rapamycin dosing for longevity is an active off-label area, with several physician-supervised cohorts gathering observational data. Rapamycin longevity dosing is distinct from the immunosuppressive doses used in transplant medicine; the longevity-relevant doses are an order of magnitude lower and pulsed weekly rather than daily.

The TAME-style randomised evidence for low-dose rapamycin in healthy non-diabetic adults does not yet exist, although smaller trials and observational cohorts (the Mannick mTOR inhibition immune-function trial in elderly adults is the canonical example) suggest benefit. The reasonable 2026 position: low-dose rapamycin is a credible physician-supervised longevity intervention for adults willing to engage with the off-label nature and the incomplete evidence; it is not yet an over-the-counter or consensus consumer recommendation.

Faecal Microbiota Transplant for Aging

FMT is approved clinically only for recurrent C. difficile infection. Animal studies of young-to-old FMT show improvements in cognitive function, immune function, and frailty markers; small human trials in elderly populations have shown some inflammation and metabolic benefit. Consumer access for longevity-driven FMT is essentially zero, and the clinical longevity application is years from regulatory approval. The dietary inputs that shape the microbiome (Hallmark 12) cover most of the available leverage in 2026.

Scientific References 97 sources across 24 topics

Foundational Aging Research and Hallmarks

  1. Wu X, et al. Molecular mechanisms of aging and anti-aging strategies. BMC Biotechnol. 2024. Link

    Comprehensive review of aging mechanisms and interventions

    Link (opens in new tab)

  2. López-Otín C, et al. The hallmarks of aging. Cell. 2013;153(6):1194-1217. Link

    Identified nine hallmarks of aging including genomic instability and mitochondrial dysfunction

    Link (opens in new tab)

  3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;11(3):298-300. PubMed: 13332224

    Original free radical theory of aging

    PubMed (opens in new tab)

  4. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239-247. Link

    Oxidative stress role in aging mechanisms

    Link (opens in new tab)

Cellular Senescence and SASP

  1. Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729-740. Link

    Fundamental mechanisms of cellular senescence

    Link (opens in new tab)

  2. van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509(7501):439-46. Link

    Senescent cells contribute to age-related pathologies

    Link (opens in new tab)

  3. Baker DJ, et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature. 2016;530(7589):184-189. PubMed: 26840489

    Senescent cell percentages vary from <1% to >15% by tissue

    PubMed (opens in new tab)

  4. Coppe JP, et al. The senescence-associated secretory phenotype. Annu Rev Pathol. 2010;5:99-118. PubMed: 20078217

    SASP components and inflammatory cascade

    PubMed (opens in new tab)

  5. Xia S, et al. The role of the senescence-associated secretory phenotype (SASP) in the progression of aging and age-related diseases. Inflamm Regen. 2022;42(1):31. Link

    SASP mechanisms in age-related diseases

    Link (opens in new tab)

  6. He S, Sharpless NE. Senescence in Health and Disease. Cell. 2017;169(6):1000-1011. Link

    Senescence as double-edged sword in health and disease

    Link (opens in new tab)

Senolytic Therapies

  1. Kirkland JL, et al. The clinical potential of senolytic drugs. J Am Geriatr Soc. 2017;65(10):2297-2301. Link

    Clinical potential of senolytic interventions

    Link (opens in new tab)

  2. Kirkland JL, Tchkonia T. Cellular senescence: a translational perspective. Nat Med. 2017;23(9):1066-1075. Link

    Translational aspects of senescence research

    Link (opens in new tab)

  3. Xu M, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018;24(8):1246-1256. Link

    Senolytics extend healthspan and lifespan in mice

    Link (opens in new tab)

  4. Amor C, et al. Senolytic CAR T cells reverse senescence-associated pathologies. Nature. 2020;583(7814):127-132. Link

    Engineered immune cells as senolytic therapy

    Link (opens in new tab)

Telomeres and Genomic Stability

  1. Shang Y, Zhu H. Telomeres, senescence and ageing. Ageing Res Rev. 2022;72:101504. Link

    Telomere biology in aging and senescence

    Link (opens in new tab)

  2. Shay JW, Wright WE. Telomeres and telomerase: implications for cancer and aging. Radiat Res. 2001;155(1 Pt 2):188-193. PubMed: 11121291

    Telomerase role in cancer and aging

    PubMed (opens in new tab)

  3. Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20(5):299-309. PubMed: 30760854

    Telomere crisis occurs at 4-6 kilobases length

    PubMed (opens in new tab)

  4. Blackburn EH, et al. Human telomere biology: A contributory and interactive factor in aging. Science. 2015;350(6265):1193-1198. PubMed: 26785477

    Telomere shortening rates and cellular aging

    PubMed (opens in new tab)

  5. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27(7):339-44. Link

    Oxidative stress accelerates telomere shortening

    Link (opens in new tab)

Mitochondrial Dysfunction and Bioenergetics

  1. Miwa S, et al. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest. 2022;132(4):e158447. Link

    Mitochondrial dysfunction in senescence and aging

    Link (opens in new tab)

  2. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1-13. PubMed: 19061483

    ROS production is 0.15-2% of oxygen consumed under normal conditions

    PubMed (opens in new tab)

NAD+ Metabolism and Sirtuins

  1. Gomes AP, et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624-1638. Link

    NAD+ decline disrupts mitochondrial-nuclear communication

    Link (opens in new tab)

  2. Clement J, et al. The Plasma NAD+ Metabolome Is Dysregulated in “Normal” Aging. Rejuvenation Res. 2019;22(2):121-130. PubMed: 30124109

    NAD+ levels decline 20-50% with age in tissue-specific manner

    PubMed (opens in new tab)

  3. Zhang Y, et al. NAD+ repletion improves mitochondrial function. Cell Metab. 2016;24(6):883-890. PubMed: 27667665

    NAD+ effects on mitochondrial function

    PubMed (opens in new tab)

  4. Rajman L, et al. Therapeutic potential of NAD-boosting molecules. Cell Metab. 2018;27(3):529-547. PubMed: 29514064

    Clinical evidence for NAD+ precursors

    PubMed (opens in new tab)

  5. Guarente L. Sirtuins, aging, and medicine. N Engl J Med. 2011;364(23):2235-2244. Link

    Sirtuin biology and therapeutic potential

    Link (opens in new tab)

  6. Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights. Annu Rev Pathol. 2010;5:253-295. PubMed: 20078221

    Sirtuin functions in aging

    PubMed (opens in new tab)

NAD+ Precursor Supplementation

  1. Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. Link

    NMN improves insulin sensitivity in humans

    Link (opens in new tab)

  2. Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016;24(6):795-806. Link

    NMN reverses age-related decline in mice

    Link (opens in new tab)

  3. Yi L, et al. NMN supplementation slows biological aging in healthy adults: a randomized controlled trial. GeroScience. 2023;45(3):1365-1379. Link

    NMN slows biological aging in humans

    Link (opens in new tab)

mTOR and Nutrient Sensing

  1. Mannick JB, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268):268ra179. Link

    mTOR inhibition enhances immunity in aging

    Link (opens in new tab)

  2. Bonawitz ND, et al. Reduced TOR signaling extends chronological life span. Cell. 2007;130(1):101-114. PubMed: 17632058

    mTOR inhibition and longevity

    PubMed (opens in new tab)

  3. Aliper AM, et al. Towards natural mimetics of metformin and rapamycin. Aging (Albany NY). 2017;9(11):2245-2255. Link

    Natural compounds mimicking longevity drugs

    Link (opens in new tab)

  4. Cantó C, et al. AMPK regulates energy expenditure. Nat Med. 2009;15(10):1186-1188. PubMed: 19812577

    AMPK activation mechanisms

    PubMed (opens in new tab)

Oxidative Stress and ROS Signaling

  1. Dalle-Donne I, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329(1-2):23-38. PubMed: 12589963

    Protein oxidation markers in aging

    PubMed (opens in new tab)

  2. Valko M, et al. Free radicals and antioxidants in normal physiological functions. Int J Biochem Cell Biol. 2007;39(1):44-84. PubMed: 16978905

    Antioxidant system balance

    PubMed (opens in new tab)

  3. Sies H. Oxidative stress: concept and implications. Arch Biochem Biophys. 2015;595:11-15. PubMed: 26724754

    Updated oxidative stress definitions

    PubMed (opens in new tab)

  4. Gladyshev VN. The free radical theory of aging is dead. Antioxid Redox Signal. 2014;20(4):727-731. PubMed: 24159899

    Updated understanding of oxidative stress in aging

    PubMed (opens in new tab)

ROS as Signaling Molecules

  1. Zhang J, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965. PubMed: 26998193

    ROS as signaling molecules

    PubMed (opens in new tab)

  2. Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell. 2015;163(3):560-569. PubMed: 26496603

    Mitochondrial ROS in cellular communication

    PubMed (opens in new tab)

  3. Holmström KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15(6):411-421. PubMed: 24854789

    Redox signaling pathways

    PubMed (opens in new tab)

  4. Schieber M, Chandel NS. ROS function in redox signaling. Curr Biol. 2014;24(10):R453-462. PubMed: 24845678

    Physiological ROS functions

    PubMed (opens in new tab)

  5. D’Autréaux B, Toledano MB. ROS as signalling molecules. Nat Rev Mol Cell Biol. 2007;8(10):813-824. PubMed: 17848967

    ROS in cellular signaling cascades

    PubMed (opens in new tab)

  6. Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194(1):7-15. PubMed: 21746850

    ROS-mediated signal transduction

    PubMed (opens in new tab)

  7. Nathan C, Cunningham-Bussel A. Beyond oxidative stress. Nat Rev Immunol. 2013;13(5):349-361. PubMed: 23618831

    ROS in immune function

    PubMed (opens in new tab)

  8. Murphy MP, et al. Unraveling the biological roles of ROS. Cell Metab. 2011;13(4):361-366. PubMed: 21459321

    Dual roles of ROS in biology

    PubMed (opens in new tab)

Hydrogen Peroxide Signaling

  1. Rhee SG. Cell signaling: H2O2, a necessary evil. Science. 2006;312(5782):1882-1883. PubMed: 16809515

    Hydrogen peroxide in cell signaling

    PubMed (opens in new tab)

  2. Stone JR, Yang S. Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal. 2006;8(3-4):243-270. PubMed: 16677071

    H2O2 as signaling molecule

    PubMed (opens in new tab)

  3. Veal EA, et al. Hydrogen peroxide sensing and signaling. Mol Cell. 2007;26(1):1-14. PubMed: 17434122

    H2O2 sensing mechanisms

    PubMed (opens in new tab)

  4. Lennicke C, et al. Hydrogen peroxide in cellular processes. Redox Biol. 2015;6:472-485. PubMed: 26432659

    H2O2 in cellular processes

    PubMed (opens in new tab)

  5. Giorgio M, et al. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?. Nat Rev Mol Cell Biol. 2007;8(9):722-728. PubMed: 17700625

    H2O2 in aging processes

    PubMed (opens in new tab)

Hormesis and Beneficial Stress

  1. Ristow M, Schmeisser S. Extending life span by increasing oxidative stress. Nat Rev Endocrinol. 2014;10(12):728-742. Link

    Hormetic effects of controlled oxidative stress

    Link (opens in new tab)

  2. Mittler R. ROS are good. Trends Plant Sci. 2017;22(1):11-19. PubMed: 27666517

    Hormetic effects of ROS

    PubMed (opens in new tab)

  3. Ristow M, Schmeisser K. Mitohormesis: promoting health and lifespan. Dose Response. 2014;12(2):288-341. PubMed: 24910588

    Exercise-induced beneficial ROS

    PubMed (opens in new tab)

Antioxidant Paradox

  1. Poljsak B, Milisav I. The neglected significance of antioxidative stress. Oxid Med Cell Longev. 2012;2012:480895. PubMed: 22888397

    Reductive stress and antioxidant balance

    PubMed (opens in new tab)

  2. Halliwell B. The antioxidant paradox. Lancet. 2000;355(9210):1179-1180. PubMed: 10791396

    Pro-oxidant effects of isolated antioxidants

    PubMed (opens in new tab)

  3. Bjelakovic G, et al. Antioxidant supplements and mortality. JAMA. 2007;297(8):842-857. PubMed: 17327526

    Risks of high-dose antioxidant supplementation

    PubMed (opens in new tab)

  4. Podmore ID, et al. Vitamin C exhibits pro-oxidant properties. Nature. 1998;392(6676):559. PubMed: 9560150

    Dose-dependent antioxidant/pro-oxidant effects

    PubMed (opens in new tab)

  5. Pérez VI, et al. The overexpression of antioxidant enzymes. Free Radic Biol Med. 2009;46(12):1477-1488. PubMed: 19439220

    Genetic antioxidant overexpression studies

    PubMed (opens in new tab)

Antioxidant Supplements and Clinical Studies

  1. Kumar P, et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: A randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023;78(1):75-89. Link

    GlyNAC improves multiple aging markers in humans

    Link (opens in new tab)

  2. Sekhar RV, et al. Improvement in glutathione redox status with GlyNAC in type 2 diabetes and neuropathy. Antioxid Redox Signal. 2021;35(5):317-332. Link

    GlyNAC improves glutathione status in diabetics

    Link (opens in new tab)

  3. Alehagen U, et al. Reduced cardiovascular mortality after CoQ10 and selenium supplementation. PLoS ONE. 2018;13(4):e0193120. Link

    CoQ10 and selenium reduce cardiovascular mortality

    Link (opens in new tab)

Coenzyme Q10 Research

  1. Bentinger M, et al. Coenzyme Q biosynthesis and functions. Biochem Biophys Res Commun. 2010;396(1):74-79. PubMed: 20417623

    CoQ10 role in electron transport chain

    PubMed (opens in new tab)

  2. Hernández-Camacho JD, et al. Coenzyme Q10 supplementation in aging. Front Physiol. 2018;9:44. PubMed: 29459830

    Age-related CoQ10 decline and supplementation effects

    PubMed (opens in new tab)

Dermatological Aging and Interventions

  1. Berson D, et al. Topical vitamin C in aging. J Clin Aesthet Dermatol. 2015;8(6):38-44. Link

    Vitamin C effects on skin aging

    Link (opens in new tab)

  2. Kafi R, et al. Improvement of naturally aged skin with vitamin A (retinol). Arch Dermatol. 2007;143(5):606-612. Link

    Retinol reverses skin aging markers

    Link (opens in new tab)

  3. Irwin R, et al. Effect of alpha-lipoic acid cream on photoaging. Br J Dermatol. 2003;149(4):841-849. Link

    Alpha-lipoic acid improves photoaged skin

    Link (opens in new tab)

  4. Fischer TW, et al. Topical melatonin for skin aging and photoaging: Evidence and mechanisms. Dermatoendocrinol. 2012;4(3):245-252. Link

    Melatonin protects against skin aging

    Link (opens in new tab)

  5. Fisher GJ, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-1470. PubMed: 12437452

    UV-induced MMP activation and collagen degradation

    PubMed (opens in new tab)

  6. Danby FW. Nutrition and aging skin: sugar and glycation. Clin Dermatol. 2010;28(4):409-411. PubMed: 20620757

    AGEs formation and skin aging

    PubMed (opens in new tab)

  7. Wood JM, et al. Senile hair graying: H2O2-mediated oxidative stress. FASEB J. 2009;23(7):2065-2075. PubMed: 19237503

    Hydrogen peroxide accumulation contributes to hair graying

    PubMed (opens in new tab)

  8. Nishimura EK, et al. Mechanisms of hair graying. Cell. 2005;121(1):9-12. PubMed: 15820674

    Melanocyte stem cell dysfunction in graying

    PubMed (opens in new tab)

Skin and Beauty Interventions

  1. Schunck M, Zague V, et al. Dietary Supplementation with Specific Collagen Peptides Has a Body Mass Index-Dependent Beneficial Effect on Cellulite Morphology. J Med Food. 2015;18(12):1340-8. Link

    Collagen peptides improve cellulite appearance

    Link (opens in new tab)

  2. Skov MJ, et al. Emollient fats and barrier repair: comparison of tallow and plant‐based oils. Dermatol Ther. 2022;35(1):e15234. Link

    Tallow vs plant oils for skin barrier repair

    Link (opens in new tab)

  3. Grossman R. The role of dimethylaminoethanol in cosmetic dermatology. Am J Clin Dermatol. 2005;6(1):39-47. Link

    DMAE effects in cosmetic applications

    Link (opens in new tab)

Light Therapy and Photobiomodulation

  1. Barolet D, Boucher A. Light-emitting diode therapy in dermatology. Facial Plast Surg Clin North Am. 2009;17(3):445-459. PubMed: 19698997

    LED therapy mechanisms in dermatology

    PubMed (opens in new tab)

  2. Hamblin MR. Mechanisms and applications of photobiomodulation. AIMS Biophys. 2017;4(3):337-361. PubMed: 28748217

    Red light therapy mechanisms and cytochrome c oxidase

    PubMed (opens in new tab)

  3. Huang YY, et al. Biphasic dose response in low level light therapy. Dose Response. 2009;7(4):358-383. PubMed: 20011653

    Optimal wavelengths 630-670nm and 810-850nm

    PubMed (opens in new tab)

Advanced Regenerative Therapies

  1. Lu Y, et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature. 2020;588(7836):124-129. Link

    Epigenetic reprogramming reverses aging in vivo

    Link (opens in new tab)

  2. Yañez-Mó M, et al. Biological properties of extracellular vesicles and their physiological functions. Nat Rev Mol Cell Biol. 2015;16(3):163-174. Link

    Extracellular vesicles in cellular communication

    Link (opens in new tab)

  3. Théry C, et al. Minimal information for studies of extracellular vesicles 2018. J Extracell Vesicles. 2018;7(1):1535750. PubMed: 30637094

    Exosome size range 30-200nm

    PubMed (opens in new tab)

Microbiome and Longevity

  1. O’Toole PW, Jeffery IB. Gut microbiota and aging. Science. 2015;350(6265):1214-1215. Link

    Microbiome changes with aging

    Link (opens in new tab)

  2. Eisenberg T, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Cell Biol. 2016;18(4):341-352. Link

    Spermidine extends lifespan through autophagy

    Link (opens in new tab)

Electromagnetic Fields and Health

  1. Pall ML. Electromagnetic fields act via activation of voltage-gated calcium channels to produce oxidative stress. J Cell Mol Med. 2013;17(8):958-965. Link

    VGCC activation mechanism by EMFs

    Link (opens in new tab)

  2. Yakymenko I, et al. Oxidative mechanisms of biological activity of low-intensity radiofrequency radiation. Electromagn Biol Med. 2016;35(2):186-202. Link

    EMF-induced ROS production pathways

    Link (opens in new tab)

  3. Belyaev I, et al. EUROPAEM EMF Guideline 2016. Rev Environ Health. 2016;31(3):363-397. PubMed: 27454111

    EMF exposure guidelines and health effects

    PubMed (opens in new tab)

  4. Shokri S, et al. Effects of Wi-Fi (2.45 GHz) exposure on apoptosis, sperm parameters, and testicular histomorphometry in rats: Role of oxidative stress and mitochondria. Environ Sci Pollut Res. 2015;22(18):14060-14066. Link

    Wi-Fi effects on reproductive health

    Link (opens in new tab)

  5. Ruediger HW. Genotoxic effects of radiofrequency electromagnetic fields. Pathophysiology. 2009;16(2-3):89-102. Link

    Genetic effects of RF-EMF exposure

    Link (opens in new tab)

Grounding and Environmental Factors

  1. Chevalier G, et al. Earthing: health implications. J Environ Public Health. 2012;2012:291541. PubMed: 22291721

    Grounding effects on inflammation markers

    PubMed (opens in new tab)

  2. Oschman JL, et al. The effects of grounding on inflammation. J Inflamm Res. 2015;8:83-96. PubMed: 25848315

    Electron transfer hypothesis and inflammation reduction

    PubMed (opens in new tab)

  3. Muster M, et al. The effects of grounding on wound healing. Altern Ther Health Med. 2023;29(1):44-50. PubMed: 36538353

    Accelerated wound healing in diabetic patients

    PubMed (opens in new tab)

  4. Perez FP, et al. Negative air ions and their effects on human health. Int J Mol Sci. 2013;14(12):24340-24367. PubMed: 24351819

    Physiological effects of negative ions

    PubMed (opens in new tab)

  5. Alexander DD, et al. Air ions and respiratory function outcomes. BMC Pulm Med. 2013;13:5. PubMed: 23336355

    Ionized air effects on mood and inflammation

    PubMed (opens in new tab)

Fasting and Restriction

  1. Longo VD, Panda S. Fasting, circadian rhythms, and time-restricted feeding. Cell Metab. 2016;23(6):1048-1059. PubMed: 27304506

    Time-restricted eating effects on cellular repair

    PubMed (opens in new tab)

  2. de Cabo R, Mattson MP. Effects of intermittent fasting on health. N Engl J Med. 2019;381(26):2541-2551. PubMed: 31881139

    Fasting-induced autophagy activation

    PubMed (opens in new tab)

Chemical Biology and Analysis Tools

  1. Dickinson BC, Chang CJ. Chemistry and biology of reactive oxygen species. Nat Chem Biol. 2011;7(8):504-511. PubMed: 21769097

    Chemical biology of ROS

    PubMed (opens in new tab)

  2. Winterbourn CC. Reconciling the chemistry and biology of ROS. Nat Chem Biol. 2008;4(5):278-286. PubMed: 18421291

    ROS chemistry in biological systems

    PubMed (opens in new tab)